Cargando…
β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion
Virus infection may induce excessive interferon (IFN) responses that can lead to host tissue injury or even death. β-arrestin 2 regulates multiple cellular events through the G protein-coupled receptor (GPCR) signaling pathways. Here we demonstrate that β-arrestin 2 also promotes virus-induced produ...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691508/ https://www.ncbi.nlm.nih.gov/pubmed/33243993 http://dx.doi.org/10.1038/s41467-020-19849-9 |
_version_ | 1783614306144747520 |
---|---|
author | Zhang, Yihua Li, Manman Li, Liuyan Qian, Gui Wang, Yu Chen, Zijuan Liu, Jing Fang, Chao Huang, Feng Guo, Daqiao Zou, Quanming Chu, Yiwei Yan, Dapeng |
author_facet | Zhang, Yihua Li, Manman Li, Liuyan Qian, Gui Wang, Yu Chen, Zijuan Liu, Jing Fang, Chao Huang, Feng Guo, Daqiao Zou, Quanming Chu, Yiwei Yan, Dapeng |
author_sort | Zhang, Yihua |
collection | PubMed |
description | Virus infection may induce excessive interferon (IFN) responses that can lead to host tissue injury or even death. β-arrestin 2 regulates multiple cellular events through the G protein-coupled receptor (GPCR) signaling pathways. Here we demonstrate that β-arrestin 2 also promotes virus-induced production of IFN-β and clearance of viruses in macrophages. β-arrestin 2 interacts with cyclic GMP-AMP synthase (cGAS) and increases the binding of dsDNA to cGAS to enhance cyclic GMP-AMP (cGAMP) production and the downstream stimulator of interferon genes (STING) and innate immune responses. Mechanistically, deacetylation of β-arrestin 2 at Lys171 facilitates the activation of the cGAS–STING signaling and the production of IFN-β. In vitro, viral infection induces the degradation of β-arrestin 2 to facilitate immune evasion, while a β-blocker, carvedilol, rescues β-arrestin 2 expression to maintain the antiviral immune response. Our results thus identify a viral immune-evasion pathway via the degradation of β-arrestin 2, and also hint that carvedilol, approved for treating heart failure, can potentially be repurposed as an antiviral drug candidate. |
format | Online Article Text |
id | pubmed-7691508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-76915082020-12-03 β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion Zhang, Yihua Li, Manman Li, Liuyan Qian, Gui Wang, Yu Chen, Zijuan Liu, Jing Fang, Chao Huang, Feng Guo, Daqiao Zou, Quanming Chu, Yiwei Yan, Dapeng Nat Commun Article Virus infection may induce excessive interferon (IFN) responses that can lead to host tissue injury or even death. β-arrestin 2 regulates multiple cellular events through the G protein-coupled receptor (GPCR) signaling pathways. Here we demonstrate that β-arrestin 2 also promotes virus-induced production of IFN-β and clearance of viruses in macrophages. β-arrestin 2 interacts with cyclic GMP-AMP synthase (cGAS) and increases the binding of dsDNA to cGAS to enhance cyclic GMP-AMP (cGAMP) production and the downstream stimulator of interferon genes (STING) and innate immune responses. Mechanistically, deacetylation of β-arrestin 2 at Lys171 facilitates the activation of the cGAS–STING signaling and the production of IFN-β. In vitro, viral infection induces the degradation of β-arrestin 2 to facilitate immune evasion, while a β-blocker, carvedilol, rescues β-arrestin 2 expression to maintain the antiviral immune response. Our results thus identify a viral immune-evasion pathway via the degradation of β-arrestin 2, and also hint that carvedilol, approved for treating heart failure, can potentially be repurposed as an antiviral drug candidate. Nature Publishing Group UK 2020-11-26 /pmc/articles/PMC7691508/ /pubmed/33243993 http://dx.doi.org/10.1038/s41467-020-19849-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zhang, Yihua Li, Manman Li, Liuyan Qian, Gui Wang, Yu Chen, Zijuan Liu, Jing Fang, Chao Huang, Feng Guo, Daqiao Zou, Quanming Chu, Yiwei Yan, Dapeng β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion |
title | β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion |
title_full | β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion |
title_fullStr | β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion |
title_full_unstemmed | β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion |
title_short | β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion |
title_sort | β-arrestin 2 as an activator of cgas-sting signaling and target of viral immune evasion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691508/ https://www.ncbi.nlm.nih.gov/pubmed/33243993 http://dx.doi.org/10.1038/s41467-020-19849-9 |
work_keys_str_mv | AT zhangyihua barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT limanman barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT liliuyan barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT qiangui barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT wangyu barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT chenzijuan barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT liujing barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT fangchao barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT huangfeng barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT guodaqiao barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT zouquanming barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT chuyiwei barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion AT yandapeng barrestin2asanactivatorofcgasstingsignalingandtargetofviralimmuneevasion |